MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Chronic Myeloid Leukemia Treatments
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,136 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,136 works in the cohort · of 4,299,418page 3 of 23

Labels cover 0 of 1,136 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,136 of 1,136 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: results of <scp>SWOG</scp> S0325, an intergroup randomized <scp>PHASE II</scp> trial in newly diagnosed chronic phase chronic myeloid leukaemia
Michael W. Deininger, Kenneth J. Kopecky, Jerald P. Radich, Suzanne Kamel‐Reid, Wendy Stock, Elisabeth Paietta +8 more
2013· article· en· British Journal of Haematology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · none
64
citations
affunlabeled
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
Jason Weatherald, Louise Bondeelle, Marie‐Camille Chaumais, Christophe Guignabert, Laurent Savale, Xavier Jaïs +5 more
2020· review· en· European Respiratory Journal· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · none
60
citations
afffundunlabeled
Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia
Jaeseung Kim, Michelle Chan‐Seng‐Yue, Sabrina Ge, Andy G.X. Zeng, Karen Ng, Olga I. Gan +18 more
2023· article· en· Nature Genetics· Medicine
distilled prediction:candidate · noneconsensus · none
56
citations
affunlabeled
Phase II, randomized, multicenter, comparative study of peginterferon–α–2a (40 kD) (Pegasys®)<i>versus</i>interferon α-2a (Roferon®-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemia
Jeffrey H. Lipton, Н Д Хорошко, А К Голенков, Abdulkadyrov Km, Krishnan Padmakumari Sivaraman Nair, Tim H. Brümmendorf +2 more
2007· article· en· Leukemia & lymphoma/Leukemia and lymphoma· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · metaepi_narrow
55
citations
← previousnext →

How this was built: Screen · Findings · About